Your browser doesn't support javascript.
loading
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.
Bar-Natan, Michal; Stroopinsky, Dina; Luptakova, Katarina; Coll, Maxwell D; Apel, Arie; Rajabi, Hasan; Pyzer, Athalia R; Palmer, Kristen; Reagan, Michaela R; Nahas, Myrna R; Karp Leaf, Rebecca; Jain, Salvia; Arnason, Jon; Ghobrial, Irene M; Anderson, Kenneth C; Kufe, Donald; Rosenblatt, Jacalyn; Avigan, David.
Afiliación
  • Bar-Natan M; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Stroopinsky D; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Luptakova K; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Coll MD; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Apel A; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Rajabi H; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Pyzer AR; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Palmer K; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Reagan MR; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Nahas MR; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Karp Leaf R; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Jain S; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Arnason J; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Ghobrial IM; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Anderson KC; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Kufe D; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Rosenblatt J; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Avigan D; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Br J Haematol ; 176(6): 929-938, 2017 03.
Article en En | MEDLINE | ID: mdl-28107546
ABSTRACT
Multiple myeloma (MM) is a lethal haematological malignancy that arises in the context of a tumour microenvironment that promotes resistance to apoptosis and immune escape. In the present study, we demonstrate that co-culture of MM cells with stromal cells results in increased resistance to cytotoxic and biological agents as manifested by decreased rates of cell death following exposure to alkylating agents and the proteosome inhibitor, bortezomib. To identify the mechanism of increased resistance, we examined the effect of the co-culture of MM cells with stroma cells, on expression of the MUC1 oncogene, known to confer tumour cells with resistance to apoptosis and necrosis. Co-culture of stroma with MM cells resulted in increased MUC1 expression by tumour cells. The effect of stromal cell co-culture on MUC1 expression was not dependent on cell contact and was therefore thought to be due to soluble factors secreted by the stromal cells into the microenvironment. We demonstrated that MUC1 expression was mediated by interleukin-6 and subsequent up-regulation of the JAK-STAT pathway. Interestingly, the effect of stromal cell co-culture on tumour resistance was partially reversed by silencing of MUC1 in MM cells, consistent with the potential role of MUC1 in mediating resistance to cytotoxic-based therapies.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Médula Ósea / Comunicación Celular / Células del Estroma / Mucina-1 / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Médula Ósea / Comunicación Celular / Células del Estroma / Mucina-1 / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos